Clinical Trial Update: Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating celecoxib for preventing breast cancer in at-risk premenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED